Latest Tel Aviv Stock Exchange Stories
JERUSALEM, Jan. 6, 2013 /PRNewswire/ -- SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a voice recognition drug administration safety application announced today that Israeli's Biomedix Ltd., (TASE: BMDX), a leading Medical Device/Biotech incubator has agreed to fund and purchase SAFC shares at 0.15 cents per share. Biomedix currently holds $200,000 USD worth of SafeCode Drug Technologies shares on its books. Biomedix is an Israel-based, publicly-traded (TASE) Life...
GIVAT SHMUEL, Israel, January 2, 2013 /PRNewswire/ -- Cimatron Limited [http://www.cimatron.com ] (NASDAQ and TASE: CIMT), a leading provider of integrated CAD/CAM software solutions for the toolmaking and manufacturing industries, today announced that following its announcement of December 27, 2012 that it was seeking the delisting of its shares from the Tel Aviv Stock Exchange (TASE), it was informed that such delisting will be effective as of April 4, 2013 with the last...
GIVAT SHMUEL, Israel, December 27, 2012 /PRNewswire/ -- Cimatron Limited [http://www.cimatron.com ] (NASDAQ and TASE: CIMT) today announced that its Board of Directors has approved a cash distribution of NIS 1.60 (approximately US$0.43) per share on outstanding ordinary shares, representing a total distribution of approximately $4.0 million. The distribution is payable on February 4th, 2013 to shareholders of record at the close of business on January 17th, 2013....
MIGDAL HAEMEK, Israel, December 27, 2012 /PRNewswire/ -- TowerJazz (NASDAQ: TSEM), the global specialty foundry leader, today announced that its Chief Executive Officer, Mr. Russell Ellwanger, will present at the 15th Annual Needham Growth Conference. (Logo: http://photos.prnewswire.com/prnh/20120509/531192 ) The conference will be taking place at the New York Palace Hotel. TowerJazz is scheduled to present at the conference at 8:40am Eastern Time on Tuesday,...
HERZLIYA, Israel, December 5, 2012 /PRNewswire/ -- XTL Biopharmaceuticals Ltd (TASE: XTL) (OTC: XTLBY) (the "Company", or "XTL"), a biopharmaceutical development company that recently acquired the controlling stake of Proteologics Ltd (TASE: PRTL) announces that Mr. David Grossman, Chief Executive Officer of XTL and Mr. Efri Argaman, were appointed as members of the board of directors of Proteologics. Furthermore, the Board of Directors of Proteologics appointed Mr. Efri...
REHOVOT, Israel, December 5, 2012 /PRNewswire/ -- Sapiens International Corporation N.V. [http://www.sapiens.com ] (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announces today that Achmea Insurance Group have selected Sapiens IDIT [http://www.sapiens.com/general-insurance-software.htm ] software suite as their centralized solution for core General Insurance business in...
HAIFA, Israel, December 4, 2012 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA)(hereinafter "the Company,""ORL"), Israel's largest integrated refining and petrochemical group, announced that it has reapproved the providing of a letter of indemnity for Mr. David Federman, vice chairperson of the Company's board of directors and one of its controlling shareholders during the Company's Extraordinary General Meeting of its shareholders on December 2, 2012. 97.7% of the...
REHOVOT, Israel, November 29, 2012 /PRNewswire/ -- Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a global provider of innovative software solutions, announced today that it has signed a definitive agreement with one of its shareholders, Kardan Technologies Ltd., to buy back from Kardan two million of Sapiens' Common Shares, representing approximately 5% of the total issued and outstanding shares of Sapiens. Following consummation of the transaction, the...
TEL AVIV, Israel, November 29, 2012 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG, OTCQX: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results for the three and nine month period ended September 30, 2012. The full financial statements will be available in English on Delek Group's website at: http://www.delek-group.com. First Nine Months 2012 Highlights - Group operating profit of NIS 2.3 billion, an increase of 10% compared...
HAIFA, Israel, November 28, 2012 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ and TASE:ESLT) (the "Company") announced that a claim in the amount of approximately $40 million regarding an alleged commercial dispute was filed in the District Court of Tel-Aviv - Jaffa by Dr. Baruch Aminov against the Company, a European subsidiary of the Company and two of its officers. Based upon a preliminary review, the Company believes that there is no merit to the allegations made in the...
